Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins
- PMID: 9247295
- DOI: 10.1002/(sici)1097-0215(19970729)72:3<498::aid-ijc19>3.0.co;2-8
Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins
Abstract
Bombesin-like peptides, including the mammalian homologue gastrin-releasing peptides, are highly expressed and secreted by neuroendocrine cells in prostate carcinoma (PCa) tissues and are likely to be related to the progression of this disease. In the present study, we show that bombesin enhances the migration of androgen-independent PCa cells (PC-3) in vitro, while not affecting their adhesion to extracellular matrix proteins. The bombesin-increased motility of PC-3 cells occurs through its receptor, and, as shown with inhibitors, it likely requires activation of both protein tyrosine kinases (PTKs) and protein kinases C (PKCs). Because the focal adhesion kinase pp125FAK plays a key role in adhesion/motility and is highly expressed in advanced PCa, we examined whether in PC-3 cells bombesin signal transduction triggers the tyrosine phosphorylation of this PTK and of associated integrins and signaling proteins likely to be present in focal adhesion plaques. pp125FAK tyrosine phosphorylation was stimulated by bombesin and mimicked by PKC activation with the tumor-promotor phorbol 12-myristate-13-acetate (PMA). Moreover, this effect of bombesin on pp125FAK tyrosine phosphorylation requires the presence of both active PKC and cytoskeleton integrity since this signal was abolished by down-regulating PKCs induced by prolonged PMA treatment or by PKC inhibition with GF 109203X, as well as by disruption of the cytoskeleton with cytochalasin D. We also show that bombesin increases the tyrosine phosphorylation of a 95-kDa protein (pp95) which was co-immunoprecipitated with the alpha v and beta (3 and 5) subunits, forming integrin receptors with alpha v in PC-3 cells. The protein pp95 is distinct from the endogenously tyrosine-phosphorylated beta3 subunit. In addition, upon bombesin treatment, the beta1, beta3 and beta5 integrin subunits co-immunoprecipitated with pp125FAK and major phosphotyrosine (pY)-containing proteins of 125 and 68-70 kDa, likely corresponding to pp125FAK and paxillin. Together our data suggest that, in addition to PKC activation, tyrosine phosphorylation of pp125FAK and integrin-associated proteins may play an important role in bombesin signaling, triggering the processes of PCa cell motility and invasion.
Similar articles
-
Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma.Int J Cancer. 1996 Oct 9;68(2):164-71. doi: 10.1002/(sici)1097-0215(19961009)68:2<169::aid-ijc4>3.0.co;2-w. Int J Cancer. 1996. PMID: 8900422
-
Steel factor enhances integrin-mediated tyrosine phosphorylation of focal adhesion kinase (pp125FAK) and paxillin.Blood. 1997 Mar 1;89(5):1574-84. Blood. 1997. PMID: 9057639
-
Insulin-induced tyrosine dephosphorylation of paxillin and focal adhesion kinase requires active phosphotyrosine phosphatase 1D.Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):609-14. doi: 10.1042/bj3180609. Biochem J. 1996. PMID: 8809054 Free PMC article.
-
Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes.Cancer Surv. 1995;24:81-96. Cancer Surv. 1995. PMID: 7553664 Review.
-
Focal adhesion kinase and associated proteins.Curr Opin Cell Biol. 1994 Oct;6(5):705-10. doi: 10.1016/0955-0674(94)90097-3. Curr Opin Cell Biol. 1994. PMID: 7833050 Review.
Cited by
-
The role of FAK in tumor metabolism and therapy.Pharmacol Ther. 2014 May;142(2):154-63. doi: 10.1016/j.pharmthera.2013.12.003. Epub 2013 Dec 9. Pharmacol Ther. 2014. PMID: 24333503 Free PMC article. Review.
-
Integrin signaling aberrations in prostate cancer.Am J Transl Res. 2009 Apr 20;1(3):211-20. Am J Transl Res. 2009. PMID: 19956432 Free PMC article.
-
Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine.Int J Mol Sci. 2022 Nov 1;23(21):13334. doi: 10.3390/ijms232113334. Int J Mol Sci. 2022. PMID: 36362132 Free PMC article. Review.
-
Nonreceptor tyrosine kinases in prostate cancer.Neoplasia. 2007 Feb;9(2):90-100. doi: 10.1593/neo.06694. Neoplasia. 2007. PMID: 17357254 Free PMC article. Review.
-
Neuroendocrine differentiation in prostate cancer.Am J Transl Res. 2009 Feb 5;1(2):148-62. Am J Transl Res. 2009. PMID: 19956427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous